Overview

Efficacy Study of a Standardized Pollen Extract Preparation (Cernilton) to Treat Inflammatory Chronic Prostatitis-Chronic Pelvic Pain Syndrome (CP-CPPS)

Status:
Completed

Trial end date:
2004-01-01

Target enrollment:

Participant gender:

Summary

In this placebo controlled study the safety and efficacy of Cernilton, a standardized pollen extract, in men with inflammatory chronic prostatitis-chronic pelvic pain syndrome was investigated. The purpose of this study is to determine whether Cernilton is safe and effective in patients with inflammatory chronic prostatitis-chronic pelvic pain syndrome.

Phase:

Phase 3

Details

Lead Sponsor:

University of Giessen

Collaborators:

Cernelle, Ängelholm, Sweden
Strathmann AG&Co, Hamburg, Germany